Study on the relationship between prostate microflora and prostate cancer

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100052967

Enrollment

Unknown

Registered

2021-11-06

Start date

2021-12-01

Completion date

Unknown

Last updated

2022-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate tumor

Interventions

Prostate Cancer Group:No

benign prostatic hyperplasia control group:No

Eligibility

Sex/Gender

Male

Age

50 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for the prostate cancer group: 1. Aged > 50 years; 2. The digital rectal examination touches a hard nodule of the prostate, the boundary is not clear, there is no tenderness and the total serum PSA>4.0ng/ml; 3. Cases diagnosed with prostate cancer by prostate biopsy or pathological examination after prostate surgery; 4. Prostate magnetic resonance scan (MRI/MRS) and/or B-ultrasound showed prostate mass. Inclusion criteria for the control group: 1. Aged > 50 years; 2. Patients with benign prostatic hyperplasia after the inclusion criteria for prostate cancer were excluded.

Exclusion criteria

Exclusion criteria: 1. History of lower urinary tract symptoms; 2. A history of sexually transmitted diseases; 3. A history of urinary tract infection within 2 months; 4. Hypertension, diabetes, dyslipidemia and other metabolic diseases; 5. Have autoimmune diseases; 6. There are other systemic malignant tumors.

Design outcomes

Primary

Measure	Time frame
Blood PSA;Gleason score for prostate cancer;TNM staging of prostate cancer;	—

Countries

China

Contacts

Public ContactTang Kaifa

the Affiliated Hospital of Guizhou Medical University

tangkaifa@gmc.edu.cn+86 15285182092

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026